Therapeutic effect of a histamine H2 receptor antagonist on prokinetic agent-resistant symptomatic chronic gastritis

Therapeutic effect of a histamine H2 receptor antagonist on prokinetic agent-resistant symptomatic chronic gastritis - treatment of symptomatic chronic gastritis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002248

Enrollment

Registered

2009-08-01

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic gastritis

Interventions

famotidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: mosapride-resistant patients with symptomatic chronica gastritis

Exclusion criteria

Exclusion criteria: allergy to famotidine with serious diseases pregnant or lactating female

Design outcomes

Primary

Measure	Time frame
subjective symptom	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026